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Background: It has been shown that estrogen is synthesized in the spinal dorsal horn and plays a role in
modulating pain transmission. One of the estrogen receptor (ER) subtypes, estrogen receptor alpha (ERa), is
expressed in the spinal laminae I-V, including substantia gelatinosa (SG, lamina II). However, it is unclear how ERs
are involved in the modulation of nociceptive transmission.
Results: In the present study, a selective ERa antagonist, methyl-piperidino-pyrazole (MPP), was used to test the
potential functional roles of spinal ERa in the nociceptive transmission. Using the whole-cell patch-clamp
technique, we examined the effects of MPP on SG neurons in the dorsal root-attached spinal cord slice prepared
from adult rats. We found that MPP increased glutamatergic excitatory postsynaptic currents (EPSCs) evoked by the
stimulation of either Aδ- or C-afferent fibers. Further studies showed that MPP treatment dose-dependently
increased spontaneous EPSCs frequency in SG neurons, while not affecting the amplitude. In addition, the PKC was
involved in the MPP-induced enhancement of synaptic transmission.
Conclusions: These results suggest that the selective ERa antagonist MPP pre-synaptically facilitates the excitatory
synaptic transmission to SG neurons. The nociceptive transmission evoked by Aδ- and C-fiber stimulation could be
potentiated by blocking ERa in the spinal neurons. Thus, the spinal estrogen may negatively regulate the
nociceptive transmission through the activation of ERa.
Findings
Several studies suggest that estrogen plays an important
role in the spectrum of neural functions, such as noci-
ception [1-4]. Estrogen is synthesized in many neurons
in laminae I-III of the spinal cord [5-8], and potentiates
the pain behavior [8]. Estrogen may modulate nocicep-
tive responses through the increase of glutamate-
induced currents, the inhibition of g-aminobutyric acid
(GABA) and glycine (Gly) receptors, or the modulation
of the opioid receptors in the spinal dorsal horn [9-11].
It is well known that the classical estrogen action in
neurons is to activate nuclear estrogen receptor a and b
(ERa/b), which cause long-term genomic effects [12,13],
or to activate cytoplasmic signaling events at or near the
plasma membrane [14,15] through either membrane-
localized classical ERs [16,17] or novel ERs [18]. Recent
studies showed that ERa is expressed in spinal laminae
I-V, especially in laminae I-II, and is most abundant in
the lower lumbar (L) and sacral segments [19,20]. How-
ever, whether the ERa is involved in estrogen-mediating
pain behavior remains unclear. Considering that the
superficial dorsal horn of the spinal cord, especially sub-
stantia gelatinosa (SG, lamina II), plays an important
role in the modulation of synaptic transmission of fine
myelinated A (Aδ)- and unmyelinated C-afferent fibers
[21,22], we used a selective ERa antagonist, methyl-
piperidino-pyrazole (MPP) [23], to examine the function
of spinal ERa in nociceptive transmission in SG neu-
rons. The dorsal root-attached spinal cord slices were
prepared from adult rats and recorded with whole-cell
patch-clamp technique.
Whole-cell recordings were carried out in SG neurons.
Stable recordings could be maintained in vitro for more
than 8 hrs; and recordings could be made from a single
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evoked excitatory postsynaptic currents (eEPSCs) with a
mean amplitude of 156 ± 25 pA (50~360 pA; VH =- 7 0
mV) were found in ~70% of recorded neurons (18/25).
I n8o u to ft h e s e1 8n e u r o n s( ~4 5 % ) ,s u p e r f u s i o no f
MPP (10 µM) increased the peak amplitude of the Aδ-
eEPSC in a reversible manner (Figure 1A). The enhance-
ment was averaged at 130 ± 5% (n = 8) in magnitude.
The monosynaptic C-afferent eEPSCs with a mean
amplitude of 135 ± 31 pA (40~310 pA; VH =- 7 0m V )
were found in ~60% of neurons (10/16). In 5 out of
these 10 neurons, MPP (10 μM) treatment increased the
peak amplitude of the C-eEPSC and normal Kreb’s solu-
tion washed off the MPP-induced effect (Figure 1B).
The averaged magnitude of the enhancement was 150 ±
6% (n = 5). In other three neurons exhibiting both Aδ-
and C-eEPSCs, MPP increased the amplitude of both
types of eEPSCs (Figure 1C).
Further comparison of MPP-induced enhancement
between Aδ- and C-eEPSCs showed that the increase in
C-eEPSC amplitude during MPP application was more
pronounced than that of Aδ-EPSC (Figure 1D). In spite
of the differences of their sensitivity to MPP, Aδ-a n d
C-eEPSCs were responded with a similar time course
following MPP superfusion. The current amplitudes had
been changed maximally and measured at 3 min after
MPP was applied.
To examine whether MPP modulated the afferent
synaptic transmission through pre- or post-synaptic
action, the spontaneous EPSC (sEPSC) in SG neurons
during MPP treatment were analyzed. We found that
superfusion of MPP (10 μM) resulted in a reversible
enhancement in sEPSC frequency (Figure 2A and 2B;
234 ± 9% of control at 3 min following its application,
n = 8; P < 0.001). Furthermore, the MPP-induced
responses were dose-dependent. At a concentration of
1a n d5μM, the increased sEPSC frequency was 124 ±
8% (n = 5) and 180 ± 6% (n = 5), respectively. However,
the amplitude of sEPSC was not altered by the treat-
ment with MPP (Figure 2B and 2C). The modulation on
sEPSC frequency, but not on amplitude, suggests
that MPP regulates nociceptive transmission through a
pre-synaptic action.
To investigate whether exogenous estrogen could
modulate glutamatergic excitatory synaptic transmission
in SG neurons, we tested whether a treatment with 17b-
estradiol could regulate the sEPSC. We found that the
frequency of sEPSC was reduced by bath-applied 17b-
estradiol (1 μM), and this effect could be reversed by
MPP (Figure 3A, n = 6). Finally, we also found that a
PKC inhibitor bisindolylmaleimide I hydrochloride
(BIM) (1 μM), but not a PKA inhibitor H89 (5 μM),
could reduce the MPP-induced enhancement of sEPSC
frequency (Figure 3B, n = 5).
The above results suggest that nociceptive transmis-
sion could be facilitated by blocking ERa,s u c ha sa
selective antagonist MPP used in the current study. In
addition, the endogenous estrogen may activate ERa in
spinal dorsal horn to reduce glutamatergic excitatory
transmission and inhibit the nociceptive responses. Pre-
vious studies showed that ERa is expressed in the
small-diameter neurons in the dorsal root ganglion
Figure 1 Effects of MPP on monosynaptic Aδ- or C-fiber
eEPSCs in SG neurons. (A) Average traces of six consecutive Aδ-
eEPSCs (stimulated at 0.2 Hz) before (left), during the treatment with
MPP (10 μM, middle), and 5 min after washout (right) are shown. (B)
Average traces of six consecutive C-eEPSCs (stimulated at 0.2 Hz)
before (left), during the MPP treatment (10 μM, middle), and 5 min
after washout (right) are shown. (C) Effects of MPP (10 μM) on
monosynaptic Aδ- and C-fiber eEPSCs were obtained from a single
neuron. Average traces of six consecutive eEPSCs (stimulated at 0.2
Hz) before (left), during the MPP treatment (middle), and 5 min after
washout (right) are shown. (D) The MPP-induced increase in the
amplitude of C-eEPSCs is more pronounced than that of Aδ-eEPSCs
in SG neurons. Peak amplitudes of monosynaptic C-eEPSC and Aδ-
fiber eEPSCs in the presence of MPP (10 μM) (n = 5 and 8 neurons,
respectively) were analyzed. ** P < 0.01, *** P < 0.001 (paired t-test).
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The ERa-mediated inhibition of ATP-induced Ca
2+ sig-
naling in mouse DRG neurons [27] suggests that periph-
eral ERa negatively regulates nociceptive transmission.
Moreover, ERa immunoreactivity has been found in the
spinal cord. A larger numbers of ERa-immunoreactive
neurons were found in the lower lumbar spinal cord
segments. These ERa-containing neurons were mainly
found in the spinal lamina II, and some were in laminae
I, III, IV, V, and X. In the superficial layers of the
medullary dorsal horn, ERa-immunoreactivity was
mainly located in lamina II, which was also expressed
noxious-induced Fos [19,20,28]. These findings provide
an anatomical and neurochemical basis for the hypoth-
esis that estrogen activates ERa directly to regulate pain
transmission at the central level [28]. Consistent with
early studies, our present study shows that in the spinal
dorsal horn, ERa is involved in the modulation of noci-
ceptive Aδ- and C-afferent transmission.
Previous studies showed that the enzyme aromatase cat-
alyzed the formation of estrogen from testosterone in the
gonads and other tissues, such as many nociceptive neu-
rons in the spinal laminae I-III. Moreover, the specific
nonsteroidal aromatase inhibitor, vorozole, was found to
inhibit the phosphorylation of aromatase in the spinal
cord and induce an acute inhibition of the endogenous
spinal estrogen synthesis, which could consequently lead
to the inhibition of nociceptive responses [6-8]. Some stu-
dies showed that estrogen rapidly potentiated glutamate
Figure 2 MPP-induced increase in sEPSC frequency. (A) Traces of
sEPSCs before (left) and during the MPP treatment (10 μM) (middle;
3 min after the beginning of MPP application), and after washout
(right) are shown. (B) Cumulative distributions of the inter-event
interval (left) and amplitude (right) of sEPSC before (black line),
during the MPP treatment (red line) and washout (blue line) (n =
393, 339 and 321 sEPSC events over 1 min, respectively) are
analyzed. (C) MPP only enhanced the frequency of sEPSC, but not
their amplitude, in a dose-dependent manner. ** P < 0.01,
*** P < 0.001 (paired t-test).
Figure 3 Exogenous estrogen-induced reduction of sEPSC
frequency and the involvement of PKC in MPP-induced
increase of sEPSC frequency. (A) Traces of sEPSCs before the
treatment (control), during the treatment with 17b-estradiol (1 μM),
and during the treatment with 17b-estradiol (1 μM) plus MPP (10
μM) are shown. Quantitative analysis shows that estrogen reduces
sEPSC frequency, and MPP reversed the estrogen-induced inhibition
(n = 6). (B) Traces of sEPSCs before the treatment (control), during
the MPP treatment (10 μM), during the treatment with MPP (10 μM)
plus BIM (1 μM), and during the treatment with MPP (10 μM) plus
H89 (5 μM) are shown. Quantitative analysis shows that BIM, but not
H89, inhibits MPP-induced increase in sEPSC frequency (n = 5).
** P < 0.01,
# P < 0.05 (paired t-test).
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cascade [9]. G-protein coupled to inwardly rectifying K
channels could be inhibited by the estrogen-induced
reduction of the potency of GABA and opioid receptor
agonists [18,29]. Moreover, estrogen inhibited the GABA
and Gly receptors or modulated the opioid receptor in the
spinal dorsal horn [10,11]. The estrogen-induced potentia-
tion of kainate currents and inhibition of GABA and Gly
receptors may play a role in the activation of the central
pain pathways [30-32]. Our present results show that acti-
vation of ERa by estrogen may inhibit nociceptive trans-
mission through a PKC signaling pathway. Therefore, the
ERa-mediated negative regulation of nociceptive transmis-
sion may be balanced by the effect of estrogen on other
receptors in some certain extent.
In conclusion, we propose that estrogen may inhibit
the nociceptive transmission via the ERa in the spinal
dorsal horn. Our results may help to understand the
functions and mechanisms of estrogen in pain modula-
tion, and suggest that ERa m a yb eap o t e n t i a lt a r g e ti n
relieving pain syndrome.
Materials and methods
Spinal slice preparation and whole-cell recording
Transverse spinal cord slices (~600 μm, L4 or L5 seg-
ment) with an attached dorsal root from adult rats
(male, 6-8 weeks old) were prepared with a vibrating
microslicer and perfused in the oxygen-bubbled Krebs’
solution (in mM: 117 NaCl, 3.6 KCl, 2.5 CaCl2,1 . 2
MgCl2,1 . 2N a H 2PO4,2 5N a H C O 3,a n d1 1D - g l u c o s e )
for a blind ruptured patch-clamp recording as our pre-
vious study [33]. Resistance of the patch electrodes was
typically 4~10 MΩ. The internal eletrode solution con-
tained (in mM: 135 K-gluconate, 0.5 CaCl2,2M g C l 2,
5K C l ,5E G T A ,5H E P E Sa n d5D - g l u c o s e ) .C u r r e n t s
were filtered at 2 kHz and digitized at 5 kHz (Axopatch
200B amplifier, Molecular Devices) and were analyzed
by using pCLAMP8.5 program. The membrane potential
w a sh o l da t- 7 0m V .T oe v o k eA δ- and C-fiber activa-
tion, the dorsal root stimulation was delivered with a
suction electrode which was linked to a constant-current
stimulator (Digitimer). Monosynaptic eEPSC was studied
in the presence of 20 μMb i c u c u l l i n ea n d2μMs t r y c h -
nine. Frequency and amplitude of sEPSC were analyzed
with Axograph (Molecular Devices). Afferent Aδ-o r
C-fibers were identified by the basis of the conduction
velocity (CV) of afferent fibres (Aδ:2 ~ 1 2m / s ;C :< 1 . 2
m/s) calculated from the latency of EPSC from a stimu-
lus artifact, the length of dorsal root, and the stimulus
threshold (Aδ: 10~60 μA; C: 180~620 μA). The Aδ and
C responses were considered as monosynaptic in origin
when the latency remained constant and there was no
failure during stimulation at 20 Hz for the Aδ-fiber
evoked EPSCs, and at 2 Hz for the C-fiber evoked
EPSCs. Drugs were applied through a superfusion
exchange of the solutions in the recording chamber.
The drugs used in the present studies included strych-
nine, bicuculline, MPP, 17b-estradiol (Sigma, USA), BIM
and H89 (Calbiochem, USA). All drugs except for MPP,
17b-estradiol and H89 (where dimethyl sulphoxide was
used as a solvent) were dissolved in distilled water at
1000 times the concentration in stock and kept at
-20°C. On the experimental days, they were diluted to
the desired concentration within Kreb’s solution.
Data analysis and statistics
All numerical data were presented as the mean ± S.E.M.
Statistical significance was determined as P < 0.05 using
the student’sp a i r e dt-test, n refers to the number of
neurons studied.
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